Pediatric Drug Development: Regulatory Considerations ȁ

Pediatric Drug Development: Regulatory Considerations — Complying With the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act

Related Keywords

, Pediatric Research Equity Act , Drug Administration , Pharmaceuticals For Children Act , Guidance Issuing Office , Submit Comments , Drug Evaluation , Biologics Evaluation , Best Pharmaceuticals , Children Act , Biologics Price Competition , Innovation Act ,